Cellular fuel gauge may hold the key to restricting cancer growth
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts ...
Cancer
Dec 27, 2012 |
5 / 5 (2) |
0
|
Rare genetic faults identified in families with bowel cancer
(Medical Xpress)—Rare DNA faults in two genes have been strongly linked to bowel cancer by Oxford University researchers, who sequenced the genomes of people from families with a strong history of developing ...
Cancer
Dec 24, 2012 |
not rated yet |
0
|
Better approach to treating deadly melanoma identified by scientists
(Medical Xpress)—Researchers funded by Cancer Research UK have been looking at why new drugs called "MEK inhibitors", which are currently being tested in clinical trials, aren't as effective at killing cancer cells as they ...
Cancer
Dec 19, 2012 |
not rated yet |
0
|
Cancer study overturns current thinking about gene activation
(Medical Xpress)—A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows that large regions of the genome – amounting to roughly 2% – are epigenetically activated ...
Cancer
Dec 18, 2012 |
5 / 5 (1) |
0
|
British judge rules against mother in child cancer case
A judge ruled Tuesday that a seven-year-old British boy with cancer could undergo more surgery despite his mother's opposition, which had led her to run away with her son earlier this month.
Cancer
Dec 18, 2012 |
not rated yet |
0
Study shows starving cancer cells of key nutrient slows tumour growth
Depriving cancer cells of a key amino acid dramatically cuts their ability to grow and multiply, according to a new Cancer Research UK study published in Nature.
Cancer
Dec 18, 2012 |
5 / 5 (2) |
0
|
Scientists identify a new layer of complexity within colon cancer
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumour cells and observe their growth over time. By using special immune-deficient mice to propagate human colorectal ...
Cancer
Dec 13, 2012 |
not rated yet |
0
|
Researchers discover new potential chemotherapy
Medical researchers at the University of Alberta have discovered that knocking out a particular "partner" gene is the Achilles' heel of some cancers.
Cancer
Dec 13, 2012 |
5 / 5 (1) |
0
Improved treatments for chronic myeloid leukaemia have dramatically increased survival
Survival for people diagnosed with Chronic Myeloid Leukaemia (CML) has risen by nearly half, with around 58 per cent of people surviving their disease for at least five years compared with only around 40 p ...
Cancer
Dec 12, 2012 |
not rated yet |
0
Diesel fumes increase risk of childhood brain tumours, study finds
(Medical Xpress)—A link between brain tumours in children and their parents' exposure to diesel exhaust fumes before birth has been found by researchers at The University of Western Australia-affiliated Western Australian ...
Cancer
Dec 11, 2012 |
not rated yet |
0
|
Benefit of PET or PET/CT in recurrent bowel cancer is not proven
For patients in whom a recurrence of bowel cancer is suspected, the study data currently available allow no robust conclusions as to the advantages and disadvantages of using positron emission tomography (PET), alone or in ...
Cancer
Dec 10, 2012 |
not rated yet |
0
Researchers identify proteins that indicate which kidney tumors are most likely to spread
Researchers at St. Michael's hospital have identified 29 proteins that are likely to be involved in the spread of kidney cancer. The discovery will help physicians recognize which tumours are going to behave more aggressively ...
Cancer
Dec 05, 2012 |
not rated yet |
0
Breast cancer drug could hold the key to fighting other tumours
New research out of the United Kingdom is showing that a common drug used in the fight against breast cancer could also be employed in the fight against other tumours. The drug in question is geldanamycin, ...
Cancer
Dec 05, 2012 |
5 / 5 (1) |
0
New pill could offer hope to bowel cancer and gastrointestinal stromal tumor patients after failure of standard treatmen
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel cancer or gastrointestinal stromal tumor following failure of existing treatm ...
Cancer
Nov 21, 2012 |
not rated yet |
0
Kidney tumors have a mind of their own
New research has found there are several different ways that kidney tumours can achieve the same result – namely, grow.
Cancer
Nov 21, 2012 |
3 / 5 (1) |
0
